Intracranial abscesses: some clinical pharmacology issues of a multidisciplinary approach | CMAC

Intracranial abscesses: some clinical pharmacology issues of a multidisciplinary approach

Clinical Microbiology and Antimicrobial Chemotherapy. 2025; 27(1):27-32

​ Ortenberg E.A., Veshkurtzeva I.M.
10.36488/cmac.2025.1.27-32
intracranial abscesses brain abscess antimicrobials
Section
Diseases and Pathogens
Type
Review
Publication
Clinical Microbiology and Antimicrobial Chemotherapy. 2025; 27(1):27-32

Abstract

This literature review summarizes actual data on the use of anti-infective drugs in the treatment of brain abscesses, in particular, otorinosnusogenic ones. Mainly the largest publications over the last decade concerning this issue were analyzed. The search was performed using keywords in the PubMed database. A multidisciplinary, team approach involving clinical pharmacologist increases the probability of intracranial abscesses treatment success. The choice of antibiotics should take into account local antimicrobial resistance data that has not yet been widely reflected in the current literature.

Eduard A. Ortenberg

Tyumen State Medical University, Tyumen, Russia

Veshkurtzeva I.M.

Tyumen State Medical University, Tyumen, Russia

  • 1. Bodilsen J., Dalager-Pedersen M., van de Beek D., Brouwer M.C., Nielsen H. Incidence and mortality of brain abscess in Denmark: a nationwide population-based study. Clin Microbiol Infect. 2020;26(1):95-100. DOI: 10.1016/j.cmi.2019.05.016
  • 2. Ooi S.Z.Y., Sichimba D., Dalle D.U., Higginbotham G., Takoutsing B.D., Bankole N.D.A., et al. Management and outcomes of paediatric intracranial suppurations in lowand middle-income countries: a scoping review. Front Surg. 12;8:690895. DOI: 10.3389/fsurg.2021.690895
  • 3. Brouwer M.C., Coutinho J.M., van de Beek D. Clinical characteristics and outcome of brain abscess: systematic review and meta-analysis. Neurology. 2014;82(9):806-813. DOI: 10.1212/WNL.0000000000000172
  • 4. Zhang Z., Cai X., Li J., Kang X., Wang H., Zhang L., et al. Retrospective analysis of 620 cases of brain abscess in Chinese patients in a single center over a 62-year period. Acta Neurochir (Wien). 2016;158(4):733-739. DOI: 10.1007/s00701-016-2741-4
  • 5. Palchun V.T., Guseva A.L., Derbeneva M.L., Guseva O.A. Intracranial complications of inflammatory diseases of the nose and ear: meningitis and brain abscesses in adults. Otorhinolaryngology bulletin. 2019;84(6):61-68. Russian. DOI: 10.17116/otorino20198406161
  • 6. Krivopalov A.A., Leiko D.V., Scherbuk A.Y., Scherbuk Y.A., Shamkina P.A., Markova A.M. Emergency care for intracranial complications of inflammatory diseases of the nose and paranasal sinuses. Russian otorhinolaryngology. 2019;18(4):91-96. Russian. DOI: 10.18692/1810-4800-2019-4-91-96
  • 7. Sonneville R., Ruimy R., Benzonana N., Riffaud L., Carsin A., Tadié J.M., et al. ESCMID Study Group for Infectious Diseases of the Brain (ESGIB). An update on bacterial brain abscess in immunocompetent patients. Clin Microbiol Infect. 2017;23(9):614-620. DOI: 10.1016/j.cmi.2017.05.004
  • 8. Bodilsen J., D'Alessandris Q.G., Humphreys H., Iro M.A., Klein M., Last K., et al. ESCMID Study Group for Infections of the Brain (ESGIB). European society of Clinical Microbiology and Infectious Diseases guidelines on diagnosis and treatment of brain abscess in children and adults. Clin Microbiol Infect. 2024;30(1):66-89. DOI: 10.1016/j.cmi.2023.08.016
  • 9. Strachunsky L.S., Belousov Y.B., Kozlov S.N. Practical guide to anti-infective chemotherapy. Smolensk: IACMAC; 2007. 464 p. Russian.
  • 10. Palchun V.T. Otorhinolaryngology: national manual. 2nd ed., revision and additions M.: GEOTAR-Media; 2022. 1024 p. Russian.
  • 11. Bogomilsky M.R. Diseases of the ear, throat, nose in childhood: national guide. 2nd ed., rev. and suppl. M.: GEOTAR-Media; 2021. 1072 p. Russian. DOI: 10.33029/9704-6140-2-ETN-2021-1-1040
  • 12. Widdrington J.D., Bond H., Schwab U., Price D.A., Schmid M.L., McCarron B., et al. Pyogenic brain abscess and subdural empyema: presentation, management, and factors predicting outcome. Infection. 2018;46(6):785-792. DOI: 10.1007/s15010-018-1182-9
  • 13. Haddad N., Carr M., Balian S., Lannin J., Kim Y., Toth C., et al. The blood-brain barrier and pharmacokinetic/pharmacodynamic optimization of antibiotics for the treatment of central nervous system infections in adults. Antibiotics (Basel). 2022;11(12):1843. DOI: 10.3390/antibiotics11121843
  • 14. AMRbookbeta. Available at: https://amrbook.ru. Accessed August 20, 2024. Russian.
  • 15. Sahbudak Bal Z., Eraslan C., Bolat E., Avcu G., Kultursay N., Ozkinay F., et al. Brain abscess in children: a rare but serious infection. Clin Pediatr (Phila). 2018;57(5):574-579. DOI: 10.1177/0009922817733301
  • 16. Bodilsen J., Duerlund L.S., Mariager T., Brandt C.T., Petersen P.T., Larsen L., et al. DASGIB study group. Clinical features and prognostic factors in adults with brain abscess. Brain. 2023;146(4):1637-1647. DOI: 10.1093/brain/awac312
  • 17. Darlow C.A., McGlashan N., Kerr R., Oakley S., Pretorius P., Jones N., et al. Microbial aetiology of brain abscess in a UK cohort: prominent role of Streptococcus intermedius. J Infect. 2020;80(6):623-629. DOI: 10.1016/j.jinf.2020.03.011
  • 18. Cobo F. Brain abscesses caused by anaerobic microorganisms: a systematic review. Rev Esp Quimioter. 2023;36(2):152-159. DOI: 10.37201/req/114.2022
  • 19. Corsini Campioli C., Castillo Almeida N.E., O'Horo J.C, Wilson W.R., Cano E., DeSimone D.C., et al. Diagnosis, management, and outcomes of brain abscess due to gramnegative versus gram-positive bacteria. Int J Infect Dis. 2022;115:189-194. DOI: 10.1016/j.ijid.2021.12.322
  • 20. Duarte M.J., Kozin E.D., Barshak M.B., Reinshagen K., Knoll R.M., Abdullah K.G., et al. Otogenic brain abscesses: a systematic review. Laryngoscope Investig Otolaryngol. 2018;3(3):198-208. DOI: 10.1002/lio2.150
  • 21. Andersen C., Bergholt B., Ridderberg W., NørskovLauritsen N. Culture on selective media and ampliconbased sequencing of 16S rRNA from spontaneous brain abscess – the view from the diagnostic laboratory. Microbiol Spectr. 2022;10(2):e0240721. DOI: 10.1128/spectrum.02407-21
  • 22. Lee H.S., Kim J.H., Kim Y.H., Lee S. Surgically treated community-acquired brain abscess: bacteriological analysis based on predisposing infections. Jpn J Infect Dis. 2018;71(3):191-196. DOI: 10.7883/yoken.JJID.2017.425
  • 23. Hall S., Yadu S., Gaastra B., Mathad N., Sparrow O., Waters R., et al. Paediatric brain abscesses: a single centre experience. Br J Neurosurg. 2019;33(5):550-554. DOI: 10.1080/02688697.2019.1587381
  • 24. Hansen K.H., Justesen U.S., Kelsen J., Møller K., HelwegLarsen J., Fuursted K. Diagnostics with clinical microbiomebased identification of microorganisms in patients with brain abscesses – a prospective cohort study. APMIS. 2021;129(11):641-652. DOI: 10.1111/apm.13181
  • 25. Van Prehn J., van Triest M.I., Altorf-van der Kuil W., van Dijk K.; Dutch National AMR Surveillance Study Group. Third-generation cephalosporin and carbapenem resistance in Streptococcus mitis/oralis. Results from a nationwide registry in the Netherlands. Clin Microbiol Infect. 2019;25(4):518-520. DOI: 10.1016/j.cmi.2018.11.021
  • 26. Kuzmenkov A.Yu., Trushin I.V., Avramenko A.A., Edelstein M.V., Dekhnich A.V., Kozlov R.S. AMRmap: an online platform for monitoring antibiotic resistance. Kliniceskaa mikrobiologia i antimikrobnaa himioterapia. 2017;19(2):84-90. Russian.
  • 27. Zhang C., Yi Z. Brain abscess caused by Listeria monocytogenes: a case report and literature review. Ann Palliat Med. 2022;11(10):3356-3360. DOI: 10.21037/apm22-383
  • 28. Bodilsen J., Brouwer M.C., Nielsen H., Van De Beek D. Anti-infective treatment of brain abscess. Expert Rev Anti Infect Ther. 2018;16(7):565-578. DOI: 10.1080/14787210.2018.1489722
  • 29. Beach J.E., Perrott J., Turgeon R.D., Ensom M.H.H. Penetration of vancomycin into the cerebrospinal fluid: a systematic review. Clin Pharmacokinet. 2017;56(12):1479-1490. DOI: 10.1007/s40262-017-0548-y
  • 30. Chen H.A., Yang C.J., Tsai M.S., Liao C.H., Lee C.H. Linezolid as salvage therapy for central nervous system infections due to methicillin-resistant Staphylococcus aureus at two medical centers in Taiwan. J Microbiol Immunol Infect. 2020;53(6):909-915. DOI: 10.1016/j.jmii.2020.08.004
  • 31. Bahubali V.K.H., Vijayan P., Bhandari V., Siddaiah N., Srinivas D. Methicillin-resistant Staphylococcus aureus intracranial abscess: an analytical series and review on molecular, surgical and medical aspects. Indian J Med Microbiol. 2018;36(1):97-103. DOI: 10.4103/ijmm.IJMM_17_41
  • 32. Cabrera-Maqueda J.M., Fuentes Rumí L., Valero López G., Baidez Guerrero A.E., García Molina E., Díaz Pérez J., et al. Difusión de los antibióticos en el sistema nervioso central [Antibiotic diffusion to central nervous system]. Rev Esp Quimioter. 2018;31(1):1-12. PMID: 29390599.
  • 33. Nau R., Blei C., Eiffert H. Intrathecal antibacterial and antifungal therapies. Clin Microbiol Rev. 2020;33(3):e00190-19. DOI: 10.1128/CMR.00190-19
  • 34. Asquier-Khati A., Deschanvres C., Boutoille D., Lefebvre M., Le Turnier P., Gaborit B., et al. Nantes Brain Abscesses study group. Switch from parenteral to oral antibiotics for brain abscesses: a retrospective cohort study of 109 patients. J Antimicrob Chemother. 2020;75(10):3062-3066. DOI: 10.1093/jac/dkaa285
  • 35. Evans T.J., Jawad S., Kalyal N., Nadarajah A., Amarouche M., Stapleton S., et al. Retrospective review of the epidemiology, microbiology, management and outcomes of intra-cranial abscesses at a neurosurgical tertiary referral centre, 2018-2020. Ann Clin Microbiol Antimicrob. 2022;21(1):58. DOI: 10.1186/s12941-022-00550-2
  • 36. Bodilsen J., Brouwer M.C., van de Beek D., Tattevin P., Tong S., Naucler P., et al. Partial oral antibiotic treatment for bacterial brain abscess: an open-label randomized non-inferiority trial (ORAL). Trials. 2021;22(1):796. DOI: 10.1186/s13063-021-05783-8
  • 37. Gao L.Y., Xu G.R., Dai T.J. Precision diagnosis and therapy of a case of brain abscesses associated with asymptomatic pulmonary arteriovenous fistulas. BMC Infect Dis. 2020;20(1):370. DOI: 10.1186/s12879-020-05092-6
  • 38. Wang B., Zhang P., Li Y., Wang Y. Klebsiella pneumoniae-induced multiple invasive abscesses: a case report and literature review. Medicine (Baltimore). 2019;98(39): e17362. DOI: 10.1097/MD.0000000000017362
  • 39. Antkowiak Ł., Putz M., Mandera M. Clinical features, microbiology, and management of pediatric brainstem abscess. Childs Nerv Syst. 2020;36(12):2919-2926. DOI: 10.1007/s00381-020-04835-9
  • 40. Tunkel A.R., Hasbun R., Bhimraj A., Byers K., Kaplan S.L., Scheld W.M., et al. 2017 Infectious Diseases Society of America's clinical practice guidelines for healthcareassociated ventriculitis and meningitis. Clin Infect Dis. 2017;64(6):e34-e65. DOI: 10.1093/cid/ciw861
  • 41. Li C., Zhou P., Liu Y., Zhang L. Treatment of ventriculitis and meningitis after neurosurgery caused by carbapenemresistant Enterobacteriaceae (CRE): a challenging topic. Infect Drug Resist. 2023;16:3807-3818. DOI: 10.2147/IDR.S416948
  • 42. Deng Z.W., Wang J., Qiu C.F., Yang Y., Shi Z.H., Zhou J.L. A case report of intraventricular and intrathecal tigecycline infusions for an extensively drug-resistant intracranial Acinetobacter baumannii infection. Medicine (Baltimore). 2019;98(15):e15139. DOI: 10.1097/MD.0000000000015139
  • 43. Chen Y., Liu L. The treatment of nosocomial meningitis and brain abscess by carbapenem-resistant Klebsiella pneumoniae. Br J Neurosurg. 2023;37(4):634-636. DOI: 10.1080/02688697.2018.1530729
  • 44. Gofman N., To K., Whitman M., Garcia-Morales E. Successful treatment of ventriculitis caused by Pseudomonas aeruginosa and carbapenem-resistant Klebsiella pneumoniae with i.v. ceftazidime-avibactam and intrathecal amikacin. Am J Health Syst Pharm. 2018;75(13):953-957. DOI: 10.2146/ajhp170632
  • 45. Pektezel M.Y., Isikay I., Gocmen R., Inkaya A.C. Carbapenem-resistant Klebsiella pneumoniae meningitis and abscess treated with ceftazidime-avibactam. Enferm Infecc Microbiol Clin (Engl Ed). 2022;40(6):332-333. DOI: 10.1016/j.eimce.2021.03.007
  • 46. Gatti M., Virgili G., Cojutti P.G., Gaibani P., Conti M., Sturiale C., et al. Real-time optimization of pharmacodynamic target attainment at infection site during treatment of post-neurosurgical ventriculitis caused by carbapenem-resistant gram negatives with ceftazidimeavibactam-based regimens: a report of two cases. Microorganisms. 2022;10(1):154. DOI: 10.3390/microorganisms10010154
  • 47. Frattari A., Savini V., Polilli E., Cibelli D., Talamazzi S., Bosco D., et al. Ceftolozane-tazobactam and fosfomycin for rescue treatment of otogenous meningitis caused by XDR Pseudomonas aeruginosa: case report and review of the literature. IDCases. 2018;14:e00451. DOI: 10.1016/j.idcr.2018.e00451
  • 48. Tunckale T., Kavak C., Safak B., Gonen A., Erdem I. A case report of brain abscess caused by carbapenem-resistant Klebsiella pneumoniae. Rev Inst Med Trop Sao Paulo. 2023;65:e23. DOI: 10.1590/S1678-9946202365023
  • 49. Schwartz S., Cornely O.A., Hamed K., Marty F.M., Maertens J., Rahav G., et al. Isavuconazole for the treatment of patients with invasive fungal diseases involving the central nervous system. Med Mycol. 2020;58(4):417-424. DOI: 10.1093/mmy/myz103
  • 50. Ben-Ami R. Systemic antifungal therapy for invasive pulmonary infections. J Fungi (Basel). 2023;9(2):144. DOI: 10.3390/jof9020144
  • 51. Ostrowsky B., Banerjee R., Bonomo R.A., Cosgrove S.E., Davidson L., Doron S., et al. Infectious Diseases Society of America, Pediatric Infectious Diseases Society, and the Society for Healthcare Epidemiology of America. Infectious Diseases Physicians: leading the way in antimicrobial stewardship. Clin Infect Dis. 2018;66(7):995-1003. DOI: 10.1093/cid/cix1093
  • 52. Thy M., Gaudemer A., d'Humières C., Sonneville R. Brain abscess in immunocompetent patients: recent findings. Curr Opin Infect Dis. 2022;35(3):238-245. DOI: 10.1097/QCO.0000000000000833
Views
0 Abstract
0 PDF
0 Crossref citations
Shared